Brief: Cocrystal Pharma Reports 2022 Financial Results
29/03/2023 15:14
March 29 (Reuters) - Cocrystal Pharma Inc COCP.O :
* COCRYSTAL PHARMA REPORTS 2022 FINANCIAL RESULTS AND
PROVIDES
UPDATES ON ITS ANTIVIRAL DRUG DEVELOPMENT PROGRAMS
* COCRYSTAL PHARMA INC - NET LOSS FOR 2022 WAS $38.8
MILLION, OR
$4.77 PER SHARE
* COCRYSTAL PHARMA INC - REPORTED UNRESTRICTED CASH OF $37.1
MILLION AS OF DECEMBER 31, 2022
* COCRYSTAL PHARMA INC - EXPECT OUR CASH WILL BE SUFFICIENT
TO
FUND OPERATING ACTIVITIES FOR COMING YEAR
Source text for Eikon: ID:nGNX6GzTvW
Further company coverage: COCP.O
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway